BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, December 18, 2025
Breaking News: Trump administration impacts continue to roil the life sciences sector
See today's BioWorld Science
Home
» Fu Jen Catholic University develops new peptides for treatment of ALS
To read the full story,
subscribe
or
sign in
.
Neurology/psychiatric
Fu Jen Catholic University develops new peptides for treatment of ALS
Oct. 22, 2024
Fu Jen Catholic University has created peptides for use in the treatment of amyotrophic lateral sclerosis (ALS).
BioWorld Science
Neurology/psychiatric
Peptide
Patents